H. Lundbeck A/S, a Danish pharmaceutical firm focused on psychiatric and neurological treatments, recently announced its partnership with Vanderbilt University to license and advance collaborative research for treating schizophrenia cases.
Bullying, violence and other adversities witnessed or experienced by children and teens are likely to take a toll on their cardiovascular health, increasing chances of disease in adulthood, according to the American Heart Association (AHA).
Bryan Slaba, CEO of South Dakota’s Wagner Community Memorial Hospital - Avera (WCMH-A), recently received the American Hospital Association’s Rural Hospital Leadership Award for his achievements in local health outcomes.
The American Heart Association recently named attorney M. Lewis Kinard as its executive vice president, general counsel and assistant corporate secretary at its Dallas headquarters, succeeding retiring officer Lynne Darrouzet.
The second annual Peehavior survey conducted by Astellas Pharma and Ipsos Public Affairs found that many women who have symptoms of overactive bladder (OAB) have used unconventional methods when they have not had easy access to a restroom.
Pharmaceutical company Astellas Pharma has been named a Best Place to Work for lesbian, gay, bisexual and transgender equality as it obtained a perfect score on the Human Rights Campaign Foundation’s (HRC) Corporate Equality Index (CEI).
The American Medical Association (AMA) recently released a report that details how market concentration and consolidation is causing a trend of higher premiums for consumers and lower payments for physician services.
Abbott has received approval from Japan’s Ministry of Health, Labor and Welfare for the company’s MitraClip, making it the first minimally invasive device to treat people in Japan with mitral regurgitation (MR) heart disease.
A group advocating on behalf of those suffering from Alzheimer's has a word for Microsoft founder Bill Gates, who recently announced he's investing $100 million in disease research: Welcome to the fight.
Cardiac patients who received XIENCE stents reported a good quality of life and felt better sooner compared to those who underwent open-heart surgery, researchers said at a recent conference in Denver.
AbbVie plans to present data from 38 abstracts of Humira (adalimumab) and other products in the company’s investigational immunology medicine portfolio at the 2017 American College of Rheumatology (ACR)/Association for Rheumatology Health Professionals (ARHP) annual meeting Nov. 3-8, in San Diego.
Abbott said its Confirm Rx Insertable Cardiac Monitor (ICM), a smartphone compatible ICM to help physicians identify cardiac arrhythmias remotely, has been cleared by the U.S. Food and Drug Administration (FDA).